Yi Zhang Liyuan Ma Jie Liu Huijuan Zhu Lin Lu Kan Deng Wenbin Ma Hui Pan Renzhi Wang Yong Yao
10.3389/fendo.2021.673908
Front Endocrinol (Lausanne)
2021 Jul 26;12:673908.
bcl6 tp53 diffuse large b cell lymphoma high-dose methotrexate next generating sequencing primary pituitary lymphoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/34381423/
Cytoskeletal Proteins / genetics LIM Domain Proteins / genetics Lymphoma, Large B-Cell, Diffuse / pathology Mutation Pituitary Neoplasms / pathology Proto-Oncogene Proteins c-bcl-6 / genetics Tumor Suppressor Protein p53 / genetics
Cytoskeletal Proteins / genetics LIM Domain Proteins / genetics Lymphoma, Large B-Cell, Diffuse / pathology Mutation Pituitary Neoplasms / pathology Proto-Oncogene Proteins c-bcl-6 / genetics Tumor Suppressor Protein p53 / genetics Case Reports Research Support, Non-U.S. Gov't Aged Female High-Throughput Nucleotide Sequencing Humans Lymphoma, Large B-Cell, Diffuse / cerebrospinal fluid Lymphoma, Large B-Cell, Diffuse / genetics Male Middle Aged Pituitary Neoplasms / cerebrospinal fluid Pituitary Neoplasms / genetics Prognosis BCL6 protein, human Cytoskeletal Proteins LIM Domain Proteins LPP protein, human Proto-Oncogene Proteins c-bcl-6 TP53 protein, human Tumor Suppressor Protein p53
PMC8350335
34381423
Case Report: Identification of Potential Prognosis-Related TP53 Mutation and BCL6-LPP Fusion in Primary Pituitary Lymphoma by Next Generation Sequencing: Two Cases
2021